The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study
Open accessAbstract
Objectives To determine any long-term effects, 6 and 8 years after childhood enrollment, of the randomly assigned 14-month treatments in the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA; N = 436); to test whether attention-deficit/hyperactivity disorder (ADHD) symptom trajectory through 3 years predicts outcome in subsequent years; and to examine functioning level of the MTA adolescents relative to their non-ADHD peers (local normative comparison group; N = 261).Method Mixed-effects regression models with planned contrasts at 6 and 8 years tested a wide range of symptom and impairment variables assessed by parent, teacher, and youth report.Results In nearly every analysis, the originally randomized treatment groups did not differ significantly on repeated measures or newly analyzed variables (e.g., grades earned in school, arrests, psychiatric hospitalizations, other clinically relevant outcomes). Medication use decreased by 62% after the 14-month controlled trial, but adjusting for this did not change the results. ADHD symptom trajectory in the first 3 years predicted 55% of the outcomes. The MTA participants fared worse than the local normative comparison group on 91% of the variables tested.Conclusions Type or intensity of 14 months of treatment for ADHD in childhood (at age 7.0-9.9 years) does not predict functioning 6 to 8 years later. Rather, early ADHD symptom trajectory regardless of treatment type is prognostic. This finding implies that children with behavioral and sociodemographic advantage, with the best response to any treatment, will have the best long-term prognosis. As a group, however, despite initial symptom improvement during treatment that is largely maintained after treatment, children with combined-type ADHD exhibit significant impairment in adolescence. Innovative treatment approaches targeting specific areas of adolescent impairment are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Long-term follow-up studies suggest that hyperactive and impulsive behaviors tend to decrease with age, while inattentive symptoms show greater persistence and may stay life-long (Biederman et al., 2000; Molina et al., 2009).”
From A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD) (2019) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“potential longer-term efficacy could be the real advantage of tDCS over stimulant medication where effects are discontinued with discontinued drug administration and where effects appear to even wane in long-term continuous administration (Molina et al., 2009), presumably due to brain adaptation to the drug (Fusar-Poli et al., 2012).”
From Cognitive Neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) and Its Clinical Translation (2018) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such delayed consolidation effects reinforce the notion that brain self-regulation via NF affects neuroplasticity and may hence have unique longer-term efficacy compared to stimulant medication which does not affect neuroplasticity and may even loose efficacy over time (Molina et al., 2009), due to potential brain adaptation (Fusar-Poli et al., 2012).”
From Cognitive Neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) and Its Clinical Translation (2018) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As in the 2 previous guidelines, this recommendation is based on the evidence that for many individuals, ADHD causes symptoms and dysfunction over long periods of time, even into adulthood.”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite this large difference in medication use, there were no appreciable between-group differences in long-term academic achievement in reading or mathematics (Molina et al., 2009).”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is the first study of its kind, and results are consistent with other randomized evidence with less controlled designs (Molina et al., 2009; Tamm et al., 2017) in failing to support the expectation that taking stimulant medication during childhood will impact children with ADHD’s long-term academic achievement.”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have identified childhood risk factors associated with a more persistent course, including higher levels of symptoms, comorbid oppositional-defiant disorder (ODD), lower IQ, and family socioeconomic disadvantage.”
From Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood (2016) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As individuals with ADHD enter adolescence, their overt hyperactive and impulsive symptoms tend to decline, whereas their inattentive symptoms tend to persist.13,14”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“ADHD is a chronic condition; therefore, the PCC should manage children and adolescents with ADHD in the same manner that they would children and youth with special health care needs, following the principles of the chronic care model and the medical home (Table 5).”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Authors of longitudinal studies have found that ADHD treatments are frequently not maintained over time13 and impairments persist into adulthood.70”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“We are aware of only two such studies (Molina et al., 2009; Tamm et al., 2017).”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
In the citing paper
“data suggest limited longer-term benefits of stimulant and behavioral interventions, even when applied intensively for both school-age and preschool children (Molina et al., 2009; Riddle et al., 2013).”
From Improving Outcomes for Youth with ADHD: A Conceptual Framework for Combined Neurocognitive and Skill-Based Treatment Approaches (2014) · cites this paper as Molina et al., 2009
In the citing paper
“This suggests that the relative benefits of childhood treatment with stimulant medication, compared with non-pharmacological treatmentsFimprovement in cognitive deficits as well as reductions in symptom severityFmay dissipate after a 2-to 3-year period, whether or not the medication component of treatment is continued or withdrawn (Molina et al, 2009;Swanson et al, 2008a, b).”
From Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (2011) · cites this paper as Molina et al, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,374
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,635
SHAFFER, D., FISHER, P., LUCAS, C. P., DULCAN, M. K., & SCHWAB-STONE, M. E. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200001000-00014 · Cited by 3,505
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Roberts, B. W., & DelVecchio, W. F. (2000) · Psychological Bulletin · doi:10.1037/0033-2909.126.1.3 · Cited by 3,241
Mendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,592
Flagged first, then by citations
2 of the 55 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,000
Fabiano, G. A., Schatz, N. K., Morris, K. L., Willoughby, M. T., Vujnovic, R. K., Hulme, K. F., Riordan, J., Howard, M., Hennessy, D., Lewis, K., et al. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000137 · Cited by 43
Attainment, attendance, and school difficulties in UK primary schoolchildren with probable ADHD
May, F., Ford, T. J., Janssens, A. I. W. A., Newlove‐Delgado, T., Russell, A. E., Salim, J., Ukoumunne, O. C., & Hayes, R. A. (2020) · British Journal of Educational Psychology · doi:10.1111/bjep.12375 · Cited by 61
Christiansen, H., Reh, V., Schmidt, M. H., & Rief, W. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00943 · Cited by 48
Training sensory signal-to-noise resolution in children with ADHD in a global mental health setting
Mishra, J., Sagar, R., Joseph, A. A., Gazzaley, A. H., & Merzenich, M. M. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.45 · Cited by 44
Pharmacological treatment of Tourette syndrome
Gilbert, D. L., & Jankovic, J. J. (2014) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2014.04.006 · Cited by 44
Langberg, J. M., Dvorsky, M. R., Kipperman, K. L., Molitor, S. J., & Eddy, L. D. (2014) · Psychology of Addictive Behaviors · doi:10.1037/adb0000039 · Cited by 44
van Goozen, S. H. M., Langley, K., Northover, C., Hubble, K., Rubia, K., Schepman, K., O'Donovan, M. C., & Thapar, A. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12464 · Cited by 42
A mixture-model approach to linking ADHD to adolescent onset of illicit drug use.
Malone, P. S., Eck, K. V., Flory, K., & Lamis, D. A. (2010) · Developmental Psychology · doi:10.1037/a0020549 · Cited by 47
A Population-Based Study of Stimulant Drug Treatment of ADHD and Academic Progress in Children
Zoëga, H., Rothman, K. J., Huybrechts, K. F., Ólafsson, Ö., Baldursson, G., Almarsdóttir, A. B., Jónsdóttir, S., Halldórsson, M., Hernández–Dı́az, S., & Valdimarsdóttir, U. A. (2012) · PEDIATRICS · doi:10.1542/peds.2011-3493 · Cited by 42
Optimal management of ADHD in older adults
Torgersen, T., Gjervan, B., Lensing, M. B., & Rasmussen, K. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s59271 · Cited by 42
Childhood ADHD and Involvement in Early Pregnancy: Mechanisms of Risk
Meinzer, M. C., LeMoine, K. A., Howard, A. L., Stehli, A., Arnold, L. E., Hechtman, L. T., Hinshaw, S. P., Molina, B. S. G., Murray, D. W., Sibley, M. H., et al. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717730610 · Cited by 53
Self-citationChildhood attention-deficit/hyperactivity disorder
Verkuijl, N., Perkins, M., & Fazel, M. S. (2015) · BMJ · doi:10.1136/bmj.h2168 · Cited by 45
Attention-Deficit/Hyperactivity Disorder: A Shift Toward Resilience?
Modesto‐Lowe, V., Yelunina, L., & Hanjan, K. (2011) · Clinical Pediatrics · doi:10.1177/0009922810394836 · Cited by 55
Current Status of Neurofeedback for Attention-Deficit/Hyperactivity Disorder
Lofthouse, N., Arnold, L. E., & Hurt, E. A. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0301-z · Cited by 41
Self-citationCornforth, C., Sonuga-Barke, E., & Coghill, D. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791959827 · Cited by 41
Howard, A. L., Molina, B. S. G., Swanson, J. M., Hinshaw, S. P., Belendiuk, K. A., Harty, S. C., Arnold, L. E., Abikoff, H., Hechtman, L. T., Stehli, A., et al. (2015) · Addiction · doi:10.1111/add.12880 · Cited by 44
Self-citationOwens, J., & Jackson, H. M. (2016) · Social Science Research · doi:10.1016/j.ssresearch.2016.06.018 · Cited by 50
ADGRL 3 ( LPHN 3) variants are associated with a refined phenotype of ADHD in the MTA study
Acosta, M. T., Swanson, J. M., Stehli, A., Molina, B. S. G., the MTA Team, Martinez, A. F., Arcos‐Burgos, M., & Muenke, M. (2016) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.230 · Cited by 41
Self-citationLeffa, D. T., Bellaver, B., Salvi, A. A., de Oliveira, C., Caumo, W., Grevet, E. H., Fregni, F., Quincozes‐Santos, A., Rohde, L. A., & Torres, I. L. D. S. (2018) · Brain stimulation · doi:10.1016/j.brs.2018.04.001 · Cited by 46
Therapeutic and mechanistic intervention of vitamin D in neuropsychiatric disorders
Rihal, V., Khan, H., Kaur, A., Singh, T. G., & Abdel‐Daim, M. M. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114782 · Cited by 42
Lam, S.-L., Criaud, M., Lukito, S., Westwood, S. J., Agbedjro, D., Kowalczyk, O. S., Curran, S. R., Barret, N., Abbott, C., Liang, H., et al. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21100999 · Cited by 40
Hayward, A., Tomlinson, A., & Neill, J. C. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.010 · Cited by 39
Improving homework performance among children with ADHD: A randomized clinical trial.
Merrill, B. M., Morrow, A. S., Altszuler, A. R., Macphee, F. L., Gnagy, E. M., Greiner, A. R., Coles, E. K., Raiker, J. S., Coxe, S., & Pelham, W. E. (2017) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000144 · Cited by 40
Western-style diet induces insulin insensitivity and hyperactivity in adolescent male rats
Marwitz, S. E., Woodie, L. N., & Blythe, S. G. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.07.023 · Cited by 40
Frölich, J., Banaschewski, T., Döpfner, M., & Görtz‐Dorten, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.922542 · Cited by 40
Hulvershorn, L. A., Finn, P., Hummer, T. A., Leibenluft, E., Ball, B. J., Gichina, V., & Anand, A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.05.015 · Cited by 39
Merrell, C. H., Sayal, K. S., Tymms, P. B., & Kasim, A. (2016) · Learning and Individual Differences · doi:10.1016/j.lindif.2016.04.003 · Cited by 40
Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD
Chang, J.-C., Lin, H., Lv, J., Tseng, W. I., & Gau, S. S. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03040-5 · Cited by 43
Ferrín, M., & Taylor, E. A. (2011) · Future Neurology · doi:10.2217/fnl.11.5 · Cited by 42
Organisation of services for managing ADHD
Coghill, D. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000937 · Cited by 41
Denchev, P., Kaltman, J. R., Schoenbaum, M., & Vitiello, B. (2010) · Circulation · doi:10.1161/circulationaha.109.901256 · Cited by 38
Self-citationDSM-5 changes enhance parent identification of symptoms in adolescents with ADHD
Sibley, M. H., & Kuriyan, A. B. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.036 · Cited by 40
Early high school engagement in students with attention/deficit hyperactivity disorder
Zendarski, N. J., Sciberras, E., Mensah, F. K., & Hiscock, H. (2017) · British Journal of Educational Psychology · doi:10.1111/bjep.12140 · Cited by 52
Estrada‐Plana, V., Esquerda, M., Mangues, R., March‐Llanes, J., & Moya-Higueras, J. (2019) · Games for Health Journal · doi:10.1089/g4h.2018.0051 · Cited by 46
Sibley, M. H., Graziano, P. A., Coxe, S., Bickman, L., & Martin, P. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.07.907 · Cited by 38
Ferrín, M., Ruíz-Veguilla, M., Blanc-Betes, M., El, S., Lax-Pericall, T., Sinclair, M., & Taylor, E. A. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0277-6 · Cited by 42
Andersen, S. L., & Navalta, C. P. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02376.x · Cited by 40
Nigg, J. T. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy314 · Cited by 41
A Developmental Perspective on Attention-Deficit/Hyperactivity Disorder (ADHD)
Campbell, S. B. G., Halperin, J. M., & Sonuga-Barke, E. J. S. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9608-3_22 · Cited by 39
Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study
Cressman, A. M., Macdonald, E. M., Huang, A., Gomes, T., Paterson, M. J., Kurdyak, P. A., Mamdani, M. M., & Juurlink, D. N. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000406 · Cited by 37
Ludolph, A. G., Udvardi, P. T., Föhr, K. J., Henes, C., Liebau, S., Dreyhaupt, J., & Boeckers (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s50448 · Cited by 37
Preventing and Treating Child Mental Health Problems
Cuellar, A. E. (2015) · The Future of Children · doi:10.1353/foc.2015.0005 · Cited by 42
Sex, drugs, and ADHD: The effects of ADHD pharmacological treatment on teens' risky behaviors
Chorniy, A., & Kitashima, L. (2016) · Labour Economics · doi:10.1016/j.labeco.2016.06.014 · Cited by 37
DuPaul, G. J., Morgan, P. L., Farkas, G., Hillemeier, M. M., & Maczuga, S. (2017) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-017-0344-z · Cited by 42
High versus Low Intensity Summer Treatment for ADHD Delivered at Secondary School Transitions
Sibley, M. H., Coxe, S. J., Campez, M., Morley, C., Olson, S., Hidalgo-Gato, N., Gnagy, E. M., Greiner, A. R., Coles, E. K., Page, T. F., et al. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2018.1426005 · Cited by 37
Li, J. J., & Lee, S. S. (2011) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-011-9553-z · Cited by 41
Goodman, D. W. (2010) · PubMed Central · Cited by 36
The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design
Bottelier, M. A., Schouw, M. L. J., Klomp, A., Tamminga, H. G. H., Schrantee, A., Bouziane, C., de Ruiter, M. B., Boer, F., Ruhé, H. G., Denys, D. A. J. P., et al. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-48 · Cited by 36
Söderlund, G. B. W., Björk, C., & Gustafsson, P. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01331 · Cited by 36
Chacko, A., Bedard, A., Marks, D. J., Gopalan, G., Feirsen, N., Uderman, J. Z., Chimiklis, A. L., Heber, E., Cornwell, M. A., Anderson, L., et al. (2017) · Child Neuropsychology · doi:10.1080/09297049.2017.1282450 · Cited by 42
on behalf of the “Lombardy ADHD Registry Group”, Didoni, A., Sequi, M., Panei, P., & Bonati, M. R. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1050-3 · Cited by 36
Orban, S. A., Rapport, M. D., Friedman, L. M., Eckrich, S. J., & Kofler, M. J. (2017) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-017-0338-x · Cited by 35
Schweren, L., Hoekstra, P. J., van Lieshout, M., Oosterlaan, J., Rommelse, N. N. J., Buitelaar, J. K., Franke, B., & Hartman, C. A. (2018) · Psychological Medicine · doi:10.1017/s0033291718000545 · Cited by 39
Tsai, F., Tseng, W., Yang, L.-K., & Gau, S. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211873 · Cited by 38
Methylphenidate off-label use and safety
Trenque, T. C., Herlem, E., Taam, M. A., & Dramé, M. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-286 · Cited by 35
Intervention in the Context of Development: Pathways Toward New Treatments
Veenstra-VanderWeele, J., & Warren, Z. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.232 · Cited by 34
Hoza, B., McQuade, J. D., Murray-Close, D. K., Shoulberg, E. K., Molina, B. S. G., Arnold, L. E., Swanson, J. M., & Hechtman, L. T. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0033536 · Cited by 35
Self-citationNeurocognitive and Behavioral Predictors of Math Performance in Children With and Without ADHD
Antonini, T. N., Kingery, K. M., Narad, M. E., Langberg, J. M., Tamm, L., & Epstein, J. N. (2013) · Journal of Attention Disorders · doi:10.1177/1087054713504620 · Cited by 36
Self-citationDurá-Travé, T., Yoldi-Petri, M. E., Gallinas-Victoriano, F., & Zardoya-Santos, P. (2011) · Journal of Child Neurology · doi:10.1177/0883073811422752 · Cited by 34
Treatment Response to an Intensive Summer Treatment Program for Adolescents With ADHD
Sibley, M. H., Smith, B. H., Evans, S. W., Pelham, W. E., & Gnagy, E. M. (2012) · Journal of Attention Disorders · doi:10.1177/1087054711433424 · Cited by 34
On the Children's Global Assessment Scale (CGAS)
Lundh, A. (2012) · Figshare · Cited by 34
Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder: From Cells to Circuits
Minzenberg, M. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0128-7 · Cited by 36
Outcomes of child psychiatric treatment
Lundh, A., Forsman, M., Serlachius, E., Lichtenstein, P., & Landén, M. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12043 · Cited by 33
Cognitive Behavioral Treatment Outcomes in Adolescent ADHD
Antshel, K. M., Faraone, S. V., & Gordon, M. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.3.334 · Cited by 33
Weigard, A. S., Huang‐Pollock, C. L., Brown, S. D., & Heathcote, A. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000357 · Cited by 34
Rucklidge, J. J., Eggleston, M. J. F., Darling, K. A., Stevens, A. J., Kennedy, M. A., & FRAMPTON, C. M. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.09.007 · Cited by 36
Updates in technology-based interventions for attention deficit hyperactivity disorder
Lim, C. G., Lim-Ashworth, N., & Fung, D. S. S. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000643 · Cited by 34
Attention-Deficit/Hyperactivity Disorder and Telemental Health
Palmer, N. B., Myers, K., Stoep, A. V., McCarty, C. A., Geyer, J. R., & DeSalvo, A. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0132-8 · Cited by 33
Pottegård, A., Bjerregaard, B. K., Kortegaard, L. S., & Zoëga, H. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12325 · Cited by 34
Parental perceptions of the effects of exercise on behavior in children and adolescents with ADHD
Gapin, J. I., & Etnier, J. L. (2013) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2013.03.002 · Cited by 33
Gonon, F., Guilé, J.-M., & Cohen, D. (2010) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2010.02.004 · Cited by 42
Lensing, M. B., Zeiner, P., Sandvik, L., & Opjordsmoen, S. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07714 · Cited by 32
Safeguarding children's rights in psychopharmacological research: ethical and legal issues.
Kölch, M., Ludolph, A., Plener, P., Fangerau, H., Vitiello, B., & Fegert, J. (2010) · Current pharmaceutical design · doi:10.2174/138161210791959881 · Cited by 31
Self-citationBrocki, K. C., Forslund, T., Frick, M., & Bohlin, G. (2019) · Journal of Attention Disorders · doi:10.1177/1087054717693372 · Cited by 32
Genetic Insights Into ADHD Biology
Hayman, V., & Fernandez, T. V. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00251 · Cited by 32
Vergunst, F., Tremblay, R. E., Nagin, D. S., Algan, Y., Beasley, E., Park, J., Galéra, C., Vitaro, F., & Côté, S. M. (2019) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.5375 · Cited by 32
The Efficacy of Cognitive Videogame Training for ADHD and What FDA Clearance Means for Clinicians
Evans, S. W., Beauchaine, T. P., Chronis-Tuscano, A., Becker, S. P., Chacko, A., Gallagher, R., Hartung, C. M., Kofler, M. J., Schultz, B. K., Tamm, L., et al. (2021) · Evidence-Based Practice in Child and Adolescent Mental Health · doi:10.1080/23794925.2020.1859960 · Cited by 32
Trajectories of ADHD severity over 10 years from childhood into adulthood
Tandon, M., Tillman, R., Arpana Agrawal, A., & Luby, J. L. (2016) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-016-0191-8 · Cited by 42
O'Connor, B. C., Garner, A. A., Peugh, J. L., Simon, J., & Epstein, J. N. (2015) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000124 · Cited by 31
Self-citationSingh, L. J., Gaye, F., Cole, A. M., Chan, E. S. M., & Kofler, M. J. (2022) · Neuropsychology · doi:10.1037/neu0000798 · Cited by 32
Macphee, F. L., Merrill, B. M., Altszuler, A. R., Ramos, M. C., Gnagy, E. M., Greiner, A. R., Coxe, S. J., Raiker, J. S., Coles, E. K., Burger, L., et al. (2019) · School Psychology Review · doi:10.17105/spr-2017-0151.v48-3 · Cited by 31
Background, clinical features and treatment of attention deficit hyperactivity disorder in children
Warikoo, N., & Faraone, S. V. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.818977 · Cited by 33
Musser, E. D., Willoughby, M. T., Wright, S. M., Sullivan, E. L., Stadler, D. D., Olson, B. F., Steiner, R. D., & Nigg, J. T. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12662 · Cited by 32
Animals in Educational Settings
Gee, N. R., Fine, A. H., & Schuck, S. E. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801292-5.00014-6 · Cited by 34
Haugan, A.-L. J., Sund, A. M., Young, S., Thomsen, P. H., Lydersen, S., & Nøvik, T. S. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04019-6 · Cited by 42
Arnold, L. E., Ganocy, S. J., Mount, K. B., Youngstrom, E. A., Frazier, T. W., Fristad, M. A., Horwitz, S. M., Birmaher, B. B., Findling, R. L., Kowatch, R. A., et al. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.03.007 · Cited by 34
Self-citationWeiss, M., Childress, A., Mattingly, G., Nordbrock, E., Kupper, R. J., & Adjei, A. L. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0166 · Cited by 30
Lisdexamfetamine Dimesylate: A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder
Steer, C., Froelich, J., Soutullo, C. A., Johnson, M., & Shaw, M. (2012) · CNS Drugs · doi:10.2165/11634340-000000000-00000 · Cited by 30
The Role of the Thalamus in ADHD Symptomatology and Treatment
Bailey, T., & Joyce, A. W. (2015) · Applied Neuropsychology Child · doi:10.1080/21622965.2015.1005475 · Cited by 30
Challenges and Promises of Pediatric Psychopharmacology
Giles, L. L., & Martini, D. R. (2016) · Academic Pediatrics · doi:10.1016/j.acap.2016.03.011 · Cited by 31
Mizuno, K., Yoneda, T., Komi, M., Hirai, T., Watanabe, Y., & Tomoda, A. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.03.004 · Cited by 30
Long-Term Course After Adaptive Multimodal Treatment for Children With ADHD: An 8-Year Follow-Up
Döpfner, M., von Wirth, E., Breuer, D., Rademacher, C., Metternich-Kaizman, T. W., & Schürmann, S. (2016) · Journal of Attention Disorders · doi:10.1177/1087054716659138 · Cited by 32
Findling, R. L., Townsend, L. D., Brown, N. V., Arnold, L. E., Gadow, K. D., Kolko, D. J., McNamara, N., Gary, D. S., Kaplin, D. B., Farmer, C., et al. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0081 · Cited by 30
Self-citationTürk, S., Korfmacher, A.-K., Gerger, H., der Oord, S. V., & Christiansen, H. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2023.102271 · Cited by 33
Long-Term Effects of Stimulant Treatment for ADHD: What Can We Tell Our Patients?
Craig, S. G., Davies, G., Schibuk, L., Weiss, M. D., & Hechtman, L. T. (2015) · Current Developmental Disorders Reports · doi:10.1007/s40474-015-0039-5 · Cited by 34
Self-citationItem Response Theory Analysis of ADHD Symptoms in Children With and Without ADHD
Li, J. J., Reise, S. P., Chronis-Tuscano, A. M., Mikami, A. Y., & Lee, S. S. (2015) · Assessment · doi:10.1177/1073191115591595 · Cited by 31
Mitchell, J. T., Howard, A. L., Belendiuk, K. A., Kennedy, T. M., Stehli, A., Swanson, J. M., Hechtman, L. T., Arnold, L. E., Hoza, B., Vitiello, B., et al. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty045 · Cited by 32
Self-citationGaric, D., Broce, I., Graziano, P. A., Mattfeld, A. T., & Dick, A. S. (2018) · Developmental Science · doi:10.1111/desc.12744 · Cited by 30
Levi-Shachar, O., Gvirts, H. Z., Goldwin, Y., Bloch, Y., Shamay‐Tsoory, S., Zagoory‐Sharon, O., Feldman, R., & Maoz, H. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0522-5 · Cited by 32
Rich-Club Analysis in Adults With ADHD Connectomes Reveals an Abnormal Structural Core Network
Wang, B., Wang, G., Wang, X., Cao, R., Xiang, J., Yan, T., Li, H., Yoshimura, S., Toichi, M., & Zhao, S. (2019) · Journal of Attention Disorders · doi:10.1177/1087054719883031 · Cited by 32
Metadata
- Authors
- Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., Elliott, G. R., Greenhill, L. L., Newcorn, J. H., Wells, K. C., Wigal, T., Gibbons, R. D., Hur, K., & Houck, P. R.
- Affiliations
- University of Pittsburgh (US)
- University of California, Berkeley (US)
- University of California, Irvine (US)
- National Institute of Mental Health (US)
- Duke University (US)
- Long Island Jewish Medical Center (US)
- New York State Psychiatric Institute (US)
- University of Illinois Chicago (US)
- Corresponding author
- Molina, Brooke S.G.
- ORCID
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 48
- Issue
- 5
- Pages
- 484-500
- ISSN
- 0890-8567 (ISSN-L)
- PMC
- PMC3063150
- OpenAlex
- W2144385879
- Cited by
- 1,182
- References
- 55
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 37 · 2023: 39 · 2022: 53 · 2021: 44 · 2020: 69 · 2019: 79 · 2018: 59 · 2017: 85 · 2016: 108 · 2015: 92 · 2014: 109 · 2013: 76 · 2012: 94
- FWCI
- 53.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- U.S. Department of Justice
- U.S. Department of Education
- Abbott Laboratories
- Eli Lilly and Company
- Pfizer
- Sanofi
- Purdue University
- Celgene
- University of Pittsburgh (HHSN271200800008-C, U01 MH50467, N01MH 12010)
- McGill University (N01MH12008, HHSN271200800003-C)
- Purdue Pharma
- York University
- National Institutes of Health (n01mh12011-0-0-1, n01mh012009-007, n01mh12008-0-0-1, n01mh12010-0-0-1, n01mh12004-0-0-0, n01mh12007-0-0-0, n01mh012012-001)
- Medical Center, University of Pittsburgh
- University of California, Irvine (HHSN271200800006-C, N01MH 12004)
- National Institute of Mental Health (U01MH50461, N01 MH12007, N01MH-12012, N01 MH012007, U01MH50440, N01MH12008,, U01MH050467, MH-50467, N01 MH012009, U01 MH50477, N01 MH012011, U01MH050447, U01MH050440, N01 MH012012, N01 MH12009, U01MH050453, N01 MH012010, U01MH50467, U01MH050461, N01MH 12004, U01MH50453, N01MH 12010, U01MH050454, N01 MH012004, N01 MH012008)
- National Institute on Drug Abuse (HHSN271200800003C, HHSN271200800006C, N01 DA085550, N01 DA085552, HHSN271200800008C, N01 DA085549, HHSN271200800005C, N01 DA085551, N01 DA085548, HHSN271200800007C, HHSN271200800009C, N01 DA085553, N01 DA085554, R01DA012414, HHSN271200800004C)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, combined type ADHD, long-term outcomes, symptom trajectories, prognostic factors, treatment effects, medication use, adolescent functioning, academic performance, arrests, psychiatric hospitalization
- MeSH terms
- Adolescent, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Behavioral Symptoms, Child, Combined Modality Therapy, Community Mental Health Services, Female, Follow-Up Studies, Humans, Male, Psychiatric Status Rating Scales, Psychotropic Drugs, Reference Values, Regression Analysis, Case-Control Studies, Treatment Outcome, Attention Deficit and Disruptive Behavior Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
